Advertisement
Organisation › Details
BI X China
In March 2020 Boehringer Ingelheim has announced today that it will open a second branch of its digital lab BI X in July 2020. The company is therefore moving to the emerging start-up hub Shanghai in China. Boehringer Ingelheim invests an initial 3 million euros and creates 20 new jobs for digital talents developing innovative solutions for Chinese patients. The BI X headquarters in Ingelheim and the new subsidiary in Shanghai will work in close collaboration. The concept of BI X is to use digital innovation to accelerate the development of healthcare solutions and to help discovery of breakthrough treatments for humans and animals. Since its start in 2017, BI X has delivered many projects with a strong impact worldwide. Using iterative processes and continuous development, Scrum Masters, Data Scientists, Engineers and UX Designers working at BI X test and prove new applications within months. Compared to other parts of the world, the Chinese digital landscape shows great differences. By opening BI X in Shanghai, Boehringer Ingelheim wants to better identify topics and needs relevant to Chinese patients and customers. *
Start | 2020-07-01 established | |
Group | Boehringer Ingelheim (Group) | |
Industry | digital health (healthcare informatics) | |
Industry 2 | pharmaceutical | |
Region | Shanghai | |
Country | China | |
City | n. a. Shanghai | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Boehringer Ingelheim. (3/30/20). "Press Release: Boehringer Ingelheim Opens Second Branch of Digital Lab BI X in Shanghai". Shanghai. | ||
Record changed: 2023-06-26 |
Advertisement
More documents for Boehringer Ingelheim (Group)
- [1] Boehringer Ingelheim. (4/9/24). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Receives Approval for Supply of EU and US Markets". Ingelheim & Shanghai....
- [2] Boehringer Ingelheim. (1/4/24). "Press Release: Boehringer Ingelheim and 3T Biosciences Enter into a Second Partnership to Develop Next-generation Cancer Immunotherapies". Oxford....
- [3] Enara Bio Ltd.. (1/4/24). "Press Release: Boehringer Ingelheim Licenses Multiple Dark Antigens from Enara Bio to Develop Off-the-Shelf Immunotherapies for Non-small Cell Lung Cancer (NSCLC)". Oxford....
- [4] Boehringer Ingelheim. (1/3/24). "Press Release: Boehringer Ingelheim Partners with Ribo to Develop New Treatments for People with Liver Diseases". Ingelheim, Mölndal & Kunshan....
- [5] AC Immune S.A.. (12/15/23). "Press Release: AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO". Lausanne....
- [6] Boehringer Ingelheim. (11/28/23). "Press Release: Boehringer Ingelheim and IBM Collaborate to Advance Generative AI and Foundation Models for Therapeutic Antibody Development". Ingelheim & Armonk, NY....
- [7] Boehringer Ingelheim. (11/22/23). "Press Release: Boehringer Ingelheim Expands Immuno-oncology Portfolio with the Acquisition of Bacterial Cancer Therapy Specialist T3 Pharma". Ingelheim & Basel....
- [8] Glox Therapeutics Ltd.. (11/14/23). "Press Release: Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria". Glasgow....
- [9] Burning Rock Biotech Ltd.. (10/31/23). "Press Release: Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics"....
- [10] Boehringer Ingelheim. (10/2/23). "Press Release: Boehringer Ingelheim and Zeiss Join Forces to Early Detect Eye Diseases and Prevent Vision Loss". Ingelheim & Jena....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top